Cheng-pang Liu
Associate Professor
Physics
National Dong Hwa University
Taiwan
Biography
Associate Professor, Cheng-Pang Liu is workin in Physics department at National Dong Hwa University. He completed his Ph.D. from the University of Washington.
Research Interest
Theoretical Nuclear Physics
Publications
-
Soria, Jean-Charles & Smit, Egbert & Khayat, David & Besse, Benjamin & Yang, Xinqun & Hsu, Cheng-Pang & Reese, David & Wiezorek, Jeffrey & Blackhall, Fiona. Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. vol 28, pp 1527-33. 10, 2010.
-
Eichenbaum, Gary & Hsu, Cheng-Pang & Vangala, Subrahmanyam & Chen, Jing & Scicinski, Jan & Galemmo, Robert & W Tuman, Robert & Johnson, Dana. Oral Coadministration of beta-Glucuronidase to Increase Exposure of Extensively Glucuronidated Drugs That Undergo Enterohepatic Recirculation. Journal of pharmaceutical sciences. 101, 2012.
-
Tabernero, Josep & P Chawla, Sant & Kindler, Hedy & Reckamp, Karen & Gabriela Chiorean, E & S Azad, Nilofer & Craig Lockhart, A & Hsu, Cheng-Pang & Baker, Nigel & Galimi, Francesco & Beltran, Pedro & Baselga, José. Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab. Targeted oncology. 10, 2014.
